Use of the levonorgestrel-releasing intrauterine system and breast cancer

Wiebren A A Tjalma, Wiebren Tjalma, Xuan-Bich Trinh, Peter A. van Dam
Obstetrics & Gynecology · 2006 · vol. 107(1) , pp. 207–208 · doi:10.1097/01.aog.0000195269.76793.bb · PMID:16394064 · W2490688512
Other OA: closed CC0 ⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-13 ⓘ

This paper investigates the relationship between the use of the levonorgestrel-releasing intrauterine system and the risk of breast cancer.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Breast Neoplasms Breast Neoplasms Intrauterine Devices, Medicated Levonorgestrel Adult Breast Neoplasms Breast Neoplasms Dose-Response Relationship, Drug Female Finland Follow-Up Studies Humans Incidence Intrauterine Devices, Medicated Levonorgestrel Levonorgestrel Middle Aged Risk Assessment

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

References (3)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:03:30.943773+00:00
unpaywall
last seen: 2026-10-13T06:25:51.201866+00:00
License: CC0 · commercial use OK